NUDT15 and cancer: Experimentally, knocking‐down NUDT15 sensitizes the cancer cell lines to mercaptopurine treatment by inhibiting cell cycle progression and increasing apoptosis, but does not induce mercaptopurine‐related leucopenia in xenograft model.